Quarterly Results

  • Company Name :
Biocon Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532523
  • NSE Symbol:
  • BIOCON
  • P/E(TTM):
  • 307.58
  • ISIN Demat:
  • INE376G01013
  • Div & Yield%:
  • 0.10
  • EPS(TTM):
  • 1.20
  • Book Value(₹):
  • 167.08
  • Market Cap(₹Cr.):
  • 59,827.71
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars December 2025 ( Cr)September 2025 ( Cr)June 2025 ( Cr)
Gross Sales 621.30 583.30 537.10
Excise Duty 0.00 0.00 0.00
Net Sales 621.30 583.30 537.10
Other Operating Income 0.00 0.00 0.00
Other Income 74.80 133.80 61.30
Total Income 696.10 717.10 598.40
Total Expenditure 744.30 530.40 516.50
PBIDT -48.20 186.70 81.90
Interest 2.30 67.20 56.20
PBDT -50.50 119.50 25.70
Depreciation 34.00 33.80 33.30
Tax 8.90 3.20 1.10
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -17.00 11.60 -0.40
Reported Profit After Tax -76.40 70.90 -8.30
Extra-ordinary Items -187.40 0.00 0.00
Adjusted Profit After Extra-ordinary item 111.00 70.90 -8.30
EPS (Unit Curr.) -0.57 0.55 -0.07
EPS (Adj) (Unit Curr.) -0.57 0.55 -0.07
Calculated EPS (Unit Curr.) -0.57 0.53 -0.06
Calculated EPS (Adj) (Unit Curr.) -0.57 0.53 -0.06
Calculated EPS (Ann.) (Unit Curr.) -2.29 2.12 -0.25
Calculated EPS (Adj) (Ann.) (Unit Curr.) -2.29 2.12 -0.25
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 668.50 668.50 668.50
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) -7.76 32.01 15.25
PBDTM(%) -8.13 20.49 4.78
PATM(%) -12.30 12.15 -1.55